摘要
目的了解苯磺酸左旋氨氯地平治疗原发性肾小球疾病的效果。方法原发性肾小球疾病患者63例,随机分成苯磺酸左旋氨氟地平(商品名:施慧达)组(治疗组)33例,对照组30例。两组患者均采用中药、利尿药、肾血管活性药、降血药、激素及免疫抑制剂、抗凝剂等一般治疗,治疗组加用施慧达2.5~5.Omg/d,分1~2次口服,疗程6个月。结果治疗组显效11例(36.4%),有效19例(57.6%),无效2例(6.1%),仅1例出现轻微反应;与对照组比较,显效及总有效率均有统计学意义(P〈O.05)。结论苯磺酸左旋氨氯地平口服治疗原发性肾小球肾炎效果良好,不良反应低,是药物治疗原发性肾小球疾病的可靠新途径。
Objective To explore a new method to treat primary glomerulopathy (PG). Methods 33 patients with PG were treated with levamlodipine besylate tablets. Result There were 28 cases (84.8% ) in effect including 11 cases (36.4%) in excellent effect. Conclusion Levamlodipine besylate tablet is useful for primary glomerulopathy (PG), which has a excellent effectiveness and less adverse reaction.
出处
《西部医学》
2009年第10期1679-1680,共2页
Medical Journal of West China